Among the activated transcriptional factors, the expressions of E2F1, E2F2, and FOXM1 genes were shown to be more significantly upregulated in CD38+CD43+ B cells of SLE patients compared with other B cell subsets (Figure 2C and Supplementary Figure 4). This evidence concerns the gene SPN and systemic lupus erythematosus.